Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02494817 · ClinicalTrials.gov registry record · NA

HIV Prevention Toolkit for HIV-negative Male Couples

A NA study, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
298
Enrollment target

NCT02494817: Completed NA study, sponsored by University of Miami.

NCT02494817 is a NA study that has completed, run by University of Miami. The registered enrollment target is 298 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02494817, a NA study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
298 participants
Enrollment target

Study Summary

Though technology is integrated into the lives of our target population, use of any particular technology will depend on the content delivered, aesthetic appeal, and overall design. Based on the completion and analysis of data from Phase 1, the investigators were able to obtain feedback on HIV-negative male couples' attitudes toward the original content in the prevention toolkit modules. The research team, along with the web-developers, used this feedback to specifically tailor the content of the modules to fit the unique needs of the intervention's target population: at risk HIV-negative male couples. For Phase 2, the investigators conducted focus groups at each site to help identify strengths and potential areas for improvement of the prevention toolkit, which will be incorporated before piloting it in the intervention for Phase 3 of this project. After assessing the acceptability of the prevention toolkit, including the content of modules, aesthetic appeal, and overall design with HIV-negative male couples target population, the research team will pilot test whether the RCT with the prevention toolkit will help reduce HIV risk through formation and adherence to a sexual agreement, reduction in occurrences of condomless anal sex with casual sex partners, and increase testing behaviors among at-risk HIV-negative male couples. The interactive website, herein referred to as the "HIV prevention toolkit" will contain unique modules about sexual agreements and effective HIV prevention strategies.

Primary Outcome

Self-reports of yes/no to forming a sexual agreement via electronic survey

Interventions

  • BEHAVIORAL Male Couples Agreement Project

Trial Details

FieldValue
Enrollment Target 298 participants
Start Date 2015-10
Est. Completion 2016-09
Phase NA
University of Miami

721 total trials

What the finished NCT02494817 record still lists

NCT02494817 is an interventional study that assigns participants to a tested intervention. The registered 298 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 1 intervention - of which Male Couples Agreement Project is the first listed.

NCT02494817 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02494817 about?

NCT02494817 is a clinical study titled "HIV Prevention Toolkit for HIV-negative Male Couples". Though technology is integrated into the lives of our target population, use of any particular technology will depend on the content delivered, aesthetic appeal, and overall design. Based on the completion and analysis of data from Phase 1, the investigators were able to obtain feedback on HIV-negat...

What is the current status of trial NCT02494817?

This trial is currently completed. It is a NA study. The enrollment target is 298 participants. The study started on 2015-10. Estimated completion is 2016-09.

What interventions are being tested in trial NCT02494817?

The interventions under investigation include: Male Couples Agreement Project (BEHAVIORAL).

Who is sponsoring clinical trial NCT02494817?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02494817's enrollment target sits among peer trials

298 371st of 2000 higher than 1,629 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06305624 · 298 participants · NA

    Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease

  • NCT06754215 · 298 participants · NA

    Smoking Cessation Intervention Development for Homeless Youth

  • NCT06780111 · 298 participants · Phase 1

    Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

  • NCT07209358 · 298 participants · NA

    EDX110 Randomized Control Trial for Treatment of DFUs

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02494817, the US trial registry maintained by the National Library of Medicine. NCT02494817 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.